Journal article
Cancer Treatment–Induced Bone Loss in Breast and Prostate Cancer
Abstract
PURPOSE: Bone loss resulting from the treatment of breast and prostate cancer is an emerging problem. Bisphosphonates have a potential role in the prevention of this cancer treatment-induced bone loss (CTIBL).
METHODS: Studies evaluating the incidence and prevalence of CTIBL in early breast and prostate cancer patients and trials evaluating the preventative role of bisphosphonates were identified by a search of the PubMed and Cochrane Library …
Authors
Saad F; Adachi JD; Brown JP; Canning LA; Gelmon KA; Josse RG; Pritchard KI
Journal
Journal of Clinical Oncology, Vol. 26, No. 33, pp. 5465–5476
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
November 20, 2008
DOI
10.1200/jco.2008.18.4184
ISSN
0732-183X